This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Allen RP et al. (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101–119
Winkelmann J and Ferini-Strambi L (2006) Genetics of restless legs syndrome. Sleep Med Rev 10: 179–183
Paulus W and Trenkwalder C (2006) Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 5: 878–886
Allen R (2004) Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 5: 385–391
Walters AS (1995) Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10: 634–642
Berger K et al. (2004) Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 164: 196–202
Hornyak M et al. (2005) Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry 66: 1139–1145
Mizuno S et al. (2005) Prevalence of restless legs syndrome in non-institutionalized Japanese elderly. Psychiatry Clin Neurosci 59: 461–465
Nomura T et al. (2006) Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 21: 380–384
Tison F et al. (2005) Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 65: 239–246
Sevim S et al. (2003) Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 61: 1562–1569
Castillo PR et al. (2006) Prevalence of restless legs syndrome among native South Americans residing in coastal and mountainous areas. Mayo Clin Proc 81: 1345–1347
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declared associations with the following companies: Boehringer Ingelheim (consultant, speaker), GlaxoSmithKline (consultant, speaker), Novartis/Orion Pharma (consultant), and Schwarz Pharma (consultant, speaker).
Rights and permissions
About this article
Cite this article
Trenkwalder, C. Restless legs syndrome: overdiagnosed or underdiagnosed?. Nat Rev Neurol 3, 474–475 (2007). https://doi.org/10.1038/ncpneuro0552
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0552
This article is cited by
-
Restless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort study
Alzheimer's Research & Therapy (2023)
-
Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS)
BMC Nephrology (2017)
-
Restless legs syndrome in hemodialysis patients: association with depression and quality of life
Sleep and Breathing (2011)
-
Recent advances in the diagnosis, genetics and treatment of restless legs syndrome
Journal of Neurology (2009)